DON'T BUY
It is the best of the Canadian oil stocks in terms of safety and size. They have got into upgrading and refining of oil in the last few years. This is a great way to play energy but he is not enamored with the industry right now. (Analysts’ price target is $45.00)
HOLD
There is wonderful hope for them. They are one of the most successful retailers in Canada. There was slowdown in the growth rate and so they corrected. It might take two to three years but it will gradually work higher as the market adjusts to slower growth.
DON'T BUY
It is a strong play on metallurgical coal, zinc and copper. These commodities are in weak demand at the moment. Investors like pure plays. He would not own it but if you own it there is no problem.
BUY
POW-T vs. PWF-T. Great West Life is the underlying company that supports both of these stocks. They are basically the same price. POW-T trades at a discount to GWO-T. You need to believe in GWO-T to own these two companies.
BUY
POW-T vs. PWF-T. Great West Life is the underlying company that supports both of these stocks. They are basically the same price. POW-T trades at a discount to GWO-T. You need to believe in GWO-T to own these two companies.
BUY
The margins were cut by the new agreement with Air Canada. He owns it in his dividend fund.
PAST TOP PICK
(A Top Pick Mar 20/18, Down 1%) He still thinks it is amazing. There is still massive growth in front of them.
PAST TOP PICK
(A Top Pick Mar 20/18, Down 0.2%) It was one of his hopes in the medical area for great growth. They are being acquired. He is going to keep holding it.
PAST TOP PICK
(A Top Pick Mar 20/18, Down 33%) He has owned it since it went public. It has had a lot of ups and downs but is an incredibly well managed company. They have lift access as well as farm machinery businesses in addition to auto parts. He would not hesitate to buy it.
HOLD
It is well managed. They made a plethora of acquisitions. They are making tiny ones with a model that works. Don’t sell a company doing this well, although he prefers OTEX-T, which is a more sure bet. (Analysts’ price target is $11.32)
BUY
They are a core holding in the medical area. They have done well recently. They will not make a home run because they make commodities. They are big and they dominate the business. As hospital spending picks up they will get their share. You will get more upside from other companies if their drugs come through. He would not hesitate to own ABT-N. It is slow and steady.
HOLD
They suffered badly. It is going to disappear as they are being acquired. You could hold it from here.
DON'T BUY
They have hope for a bunch of new products. There is heavy competition with slow growth. He prefers OTEX-T, FB-Q, or GOOGL-Q.
HOLD
They liquidated half their business. They made a large stock buyback and that helped the stock price. It is a dividend play and he holds it just for that. The excitement is over.
HOLD
If you buy it today, it is getting acquired and you get some cash. It serves stock option plans.